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Left ventricular non-compaction (LVNC) is a rare cardiomyopathy that results from 
unsettled embryogenesis of myocardium. It is morphologically characterised by 
the presence of non-compacted, this is hypertrabeculated, myocardium of the 
left ventricle with deep endocardial recesses. The clinical spectrum of symptoms 
is very wide — from asymptomatic patients through the cases of heart failure 
to the patients requiring heart transplantation. The diagnosis is most frequently 
based on the echocardiography. LVNC is often coexisted with other heart defects 
and coronary artery abnormalities. We described a case of a 58-year-old man 
with LVNC and coronary artery anomalies. (Folia Morphol 2015; 74, 4: 518–523)
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INTRODUCTION
Non-compaction of left ventricular myocardium 
(LVNC) is a rare, underdiagnosed, congenital cardio-
myopathy resulting from an arrest of the endomy-
ocardial morphogenesis during embryonic period. 
Cardiomyopathy is anatomically characterised by 
deep trabeculations in the ventricular wall which 
define recesses communicating with main ventri-
cular cavity. Because of its spongy-like structure is 
sometimes named ‘spongy cardiomyopathy’. The 
aetiology of that heart condition is not clear. Major 
clinical correlates are heart failure (HF), arrhythmias 
and thromboembolic events. Making diagnosis is 
based on the imaging modalities, especially echocar-
diography, and is often accidental. LVNC is frequently 
coexisted with other heart abnormalities as well as 
neuromuscular disorders.
CASE REPORT
58-year-old patient with a history of ischaemic 
heart disease (currently complaints in CCS class II), ar-
terial hypertension, periodically occurring palpitations 
and lipid disorders was admitted to the Department 
of Cardiology in order to perform coronarography 
and to determine the optimal medical treatment.
Familiar history did not reveal anything significant. 
The patient had administered following medications: 
bisoprolol 5 mg once daily, ramipril 5 mg twice daily, 
trimetazidine 35 mg twice daily, atorvastatin 20 mg 
once daily and acetylsalicylic acid 75 mg once daily.
On admission, the patient’s general condition was 
good. On physical examination there were no relevant 
abnormalities. Heart rate was regular, 60/min, with 
a discreet holosystolic murmur. Blood pressure was 
130/80 mm Hg.
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An electrocardiogram (ECG) on admission reve-
aled sinus rhythm, left axis deviation with incomplete 
left bundle branch block (QRS = 110 ms), deep QS 
complexes in V1–V2 leads, lack of R-wave progression 
in the precordial leads and features of left ventricular 
hypertrophy with repolarisation changes.
In laboratory tests elevated level of total choleste-
rol and low density lipoprotein cholesterol (228 mg/
dL and 136 mg/dL, respectively) were found. Cardiac 
markers both on admission and in the control were 
negative.
Transthoracic echocardiography (TTE) revealed en-
larged diameter of left atrium (42 mm), left ventricular 
ejection fraction (LVEF) 50% and hypokinetic basal 
segments of anterior wall. In the apical projection of 
the left ventricle, typical for non-compaction, two-
-layered structure of the myocardium with hypertra-
beculated inner layer and deep recesses with blood 
contrasting visible using Doppler colour technique 
(Figs. 1, 2). Moreover, moderate mitral, tricuspid and 
pulmonary valve regurgitation were revealed.
Holter ECG monitoring revealed sinus rhythm with 
a mean frequency of 60/min, numerous premature 
supraventricular contractions (1329/day) and 113 pre-
mature ventricular beats (VEs) including one episode of 
sustained ventricular tachycardia and two pairs of VEs.
Because of clinical presentation and results of 
additional tests the patient was enrolled for invasi-
ve diagnostics of coronary artery disease. Coronary 
angiography was performed and revealed anomaly 
of coronary arteries with the circumflex artery (Cx — 
circumflex branch of left coronary artery) originating 
from the proximal segment of the right coronary 
artery (RCA) resulting in difficulties of its selective 
catheterisation. The left coronary artery (LCA) system 
revealed anterior descending artery (LAD — ante-
rior interventricular branch of left coronary artery) 
without left main coronary artery (LMCA — clinical 
designation of initial segment of left coronary artery 
before its bifurcation into LAD and Cx) (Figs. 3, 4).
Due to the doubts regarding the epicardial co-
ronary artery layout, computed tomography (CT) 
angiography was performed. CT imaging confirmed 
that LAD, not narrowed, leads directly from the left 
coronary sinus (no left main present) and Cx artery 
extends from the proximal part of large, not narro-
wed RCA, back from the aorta between it and left 
atrium (Fig. 5).
After diagnostic procedures the continuation of 
medical treatment and use of the following medica-
Figure 1. Transthoracic echocardiography of patient with left ven-
tricular non-compaction. Double-layered, foetal-like structure of the 
left ventricular myocardium with hypertrabeculated inner layer and 
deep recesses (red arrows).
Figure 2. Colour Doppler echocardiography. Blood contrasting in 
the recesses of the left ventricular wall confirming anatomical  
connection with the left ventricle cavity (blue arrow).
Figure 3. Coronary angiography. The left coronary artery system — 
left anterior descending artery with no left circumflex artery visible. 
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tions was administered: sotalol 80 mg 1-0-1 (due to 
the occurrence of ventricular arrhythmias), trimeta-
zidine 35 mg 1-0-1, ramipril 5 mg 1-0-1, atorvastatin 
20 mg 0-0-1 and low-dose of acetylsalicylic acid — 
75 mg daily. Periodical control visits in the Cardiology 
Outpatient Clinic were advised also.
DISCUSSION
The term ‘isolated non-compaction of the left 
ventricular myocardium’ was officially introduced into 
clinical practice by Chin et al. in 1990 [3] although 
the phenomenon of foetal phenotype myocardium 
in adults had been known much earlier.
The exact prevalence of LVNC is not known. Ini-
tially it was considered as a rare condition, but no-
wadays due to the wide using of imaging techniques, 
is recognised more frequently and often accidentally 
when patients undergo cardiovascular investigation 
for other reasons. According to the literature the 
prevalence of non-compacted cardiomyopathy in the 
general population ranges from 0.014% to 1.3% [10, 
14]. However it seems that the prevalence of LVNC 
may be underestimated because of its occurrence also 
in patients without clinical symptoms or because of 
subjective assessment of echocardiography findings. 
In the Australian study on the prevalence of prima-
ry cardiomyopathies in paediatric population LVNC 
accounted for 9.2% of cases and was the third most 
common cardiomyopathy beyond the dilated and 
hypertrophic cardiomyopathy [12].
The aetiology of LVNC is currently considered to 
be heterogeneously genetically determined. Seve-
ral genes that may be responsible for the disease 
development has been characterised (e.g. genes of 
mitochondrial, cytoskeletal or sarcomeric proteins) 
[17], but a small number of data and uncertain rela-
tionship between genotype and phenotype require 
further investigation on that area. Myocardium has 
meshwork-like structure in prenatal period consisting 
of fine muscle trabeculae and recesses between them 
through which the myocardium is supplied directly 
by the blood stream from the heart cavity. Between 
5 and 8 gestation week the myocardium undergoes 
reconstruction and compaction process. The process 
continues from epicardial to endocardial layer, from 
the base to the apex of the heart and from the septum 
to the free wall what is reflected in the localisation 
of non-compacted muscle in adults. Along with the 
compaction progress the development of coronary 
circulation continues. Abnormalities in coincidence 
of these processes explain frequent occurrence of co-
ronary artery anomalies in case of LVNC. LVNC morp-
hologically resembles heart muscle stopped at foetal 
period of development and embrace a continuum of 
morphological features ranging from normal appe-
arance to the characteristic for fully-expressed LVNC 
cases that is determined by the moment of stopping 
Figure 5. The system of epicardial arteries of patient with a non-
-compaction cardiomyopathy and coexisting anomaly of the coro-
nary arteries layout obtained in computed tomography angiography. 
Right-sided projection. Large and not occluded right coronary 
artery (RCA, white arrow) and circumflex artery — branched out 
from the proximal part of RCA (black arrow) are visible; RA — right 
atrium; RV — right ventricle.
Figure 4. Coronary arteries seen after catheterisation and contrast 
injection to right coronary sinus. Big, not narrowed right coronary 
artery (blue arrow) and commencing from its proximal segment cir-
cumflex artery (red arrow). Asterisk indicates right coronary sinus.
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normal development of the heart muscle compaction 
(the earlier period of development’s arrest the larger 
non-compaction of myocardium).
There are no specific for LVNC histological changes, 
although fibrosis has been described in many reports 
[4, 5]. It is worth to notice that isolated noncompaction 
may histologically differ from noncompaction asso-
ciated with other congenital heart diseases in that 
the deep intertrabecular recesses communicate with 
the left ventricular cavity in the former and both the 
coronary circulation and left ventricle in the latter [14]. 
Burke et al. [2] showed in case series (n = 14) endo-
cardial fibroelastosis was a characteristic histological 
feature, as well as anastomosing or polypoid endocar-
dial trabeculations which resulted in staghorn-shaped, 
endocardial-lined recesses. However, more studies are 
needed to investigate histological features of LVNC.
Also the spectrum of clinical symptoms in patients 
with LVNC can be very wide — from asymptomatic 
cases to the patients requiring heart transplantation. 
Clinical presentation depends mainly on whether 
LVNC is an isolated defect or coexists with other 
congenital conditions or genetic syndromes, time of 
diagnosis: in childhood or adulthood, its circumstan-
ces: diagnosis in symptomatic patients or as screening 
procedures in relatives of patients with LVNC. Typical 
symptoms of cardiomyopathy are HF complaints, 
arrhythmias and thromboembolic events. It seems 
that the clinical presentation results not from the 
non-compaction itself but rather from presence of 
non-compaction associated with end-stage HF as 
a result of LVNC. Among cardiac arrhythmias, ven-
tricular arrhythmias occur most often, but atrial fi-
brillation or Wolf–Parkinson–White syndrome could 
be also frequently present. The changes observed in 
the ECG are not specific and beside arrhythmias and 
conduction disturbances they could encompass left 
ventricular hypertrophy with repolarisation changes. 
Left bundle branch block (LBBB) is quite common 
finding in LVNC patients and could indicate for more 
advanced heart defects, but it is speculative if LBBB 
is a prognostic factor [19].
The diagnosis is based mainly on non-invasive 
imaging, especially TTE, and especially in doubtful 
cases magnetic resonance imaging (MRI) or CT could 
be of help. The most common echocardiographic 
criteria for LVNC diagnosis are those proposed by 
Jenni et al. [7] including:
— thickened myocardium with double-layered struc-
ture and the ratio of non-compacted to compac-
ted layer > 2, evaluated in end-systolic phase in 
short-axis projection;
— presence of deep recesses within the myocardium 
with the blood flow from the left ventricle visible 
in colour Doppler echocardiography technique;
— localisation of changes usually in the middle seg-
ments of free and inferior wall of the left ventricle 
as well as in the apex;
— lack of coexisting cardiac pathology.
It is worth noting that echocardiography is a quite 
subjective diagnostic method and the compliance of 
diagnosis by different echocardiographic criteria is 
quite poor, around 30% [9].
Initially, the spongy cardiomyopathy was conside-
red as very severe condition with a poor prognosis 
which resulted from a late diagnosis of patients in 
advanced stage of a disease and with severe com-
plaints. Current data suggest better outcomes, par-
ticularly when the disease is asymptomatic or early 
recognised [10, 11, 14, 16]. Conditions deteriorating 
the prognosis embrace significant advancement of HF 
symptoms (III or IV NYHA class), sustained ventricular 
tachycardia and advanced age. Some echocardiograp-
hic features such as large number of occupied seg-
ments, left ventricular end-diastolic diameter or even 
the ratio of non-compacted to compacted layer may 
also worsen the prognosis [13]. The most common 
complications include HF, ventricular arrhythmias, 
thromboembolic events and sudden cardiac death. In 
over 20% of patients with advanced stage of disease 
there are life-threatening ventricular arrhythmias in-
herent [4, 18]. Prospective French study involving 
a group of patients with LVNC showed that in the case 
of people who had LVNC detected accidentally or as 
a part of the screening procedure of burdened relati-
ves outcomes are quite good, but on the other hand 
HF or left ventricular dysfunction were associated 
with a higher risk of death and need of heart trans-
plant [6]. No changes in the ECG are associated with 
a better prognosis [15].
Treatment of patients with LVNC due to the lack 
of any causal therapy is concentrated on the major 
complications of the disease: HF, arrhythmias, pre-
vention of sudden cardiac death and thromboembo-
lic events. In patients with congestive HF, standard, 
guidelines-based treatment should be administered. 
There is some evidence that early initiation of typi-
cal HF treatment in LVNC patients with or without 
clinical symptoms, especially in the beginning of left 
ventricular dysfunction, could be beneficial and delay 
522
Folia Morphol., 2015, Vol. 74, No. 4
fully-expressed HF clinical presentation [2]. Some 
authors have demonstrated that cardiac resynchro-
nisation therapy can results in improvement of left 
ventricular function in patients with a dilated left 
ventricle coexisting with LVNC [1]. Due to the high 
risk of sudden cardiac death caused by arrhythmias an 
implantation of cardioverter-defibrillator device (ICD) 
based on conventional criteria used in HF should be 
always considered. Kobza et al. [8] demonstrated the 
validity and effectiveness of ICD implantation in both 
primary and secondary prevention of sudden cardiac 
death in patients with LVNC. Most controversial issue 
associated with LVNC therapy is anticoagulation tre-
atment. LVNC is associated with significantly higher 
risk of thromboembolic complications. Structure of 
non-compacted myocardium predisposes to forma-
tion of blood clots in deep recesses as a result of slow 
blood flow and subendocardial fibrosis. It seems, 
however, that the incidence of thromboembolic com-
plications in previous studies was overestimated due 
to more advanced stage of disease which resulted in 
recommendation of anticoagulation in every patient 
[14]. Currently the risk of thromboembolic events is 
considered to be much lower and decision if antico-
agulation therapy should be administered must be 
made individually taking into account clinical featu-
res increasing risk of thrombotic complications such 
as: impaired left ventricular systolic function, atrial 
fibrillation, previous embolic incidents or presence 
of thrombus in the left ventricle. Some data indicate 
aspirin could be effective in preventing thrombo-
embolic complications. In paediatric patients taking 
aspirin since LVNC diagnosis was made, no thrombo-
embolic complications in long-term follow-up were 
observed [11].
It is also worth to notice that some aetiopatho-
genetic features of LVNC may also accelerate the 
development of atherosclerosis [20]. In case of late 
diagnosis of LVNC, coronary insufficiency symptoms 
may be first complaints, as in described patient.
CONCLUSIONS
Summarising: the coincidence of coronary artery 
system’s anomalies with spongy cardiomyopathy, 
causing difficulties in the interpretation of diagnostic 
imaging and possibility of complications, requires 
peculiar attention during performing coronarograp-
hy and percutaneous coronary interventions. In the 
above-mentioned case the patient’s complaints of 
chest pain suggesting coronary artery disease when 
there were no narrowing of coronary vessels in coro-
narography suggests their source in abnormal myo-
cardium blood supply caused by the lack of left main 
coronary artery and its branch — circumflex artery 
— originating from the initial segment of RCA as well 
as remnants of abnormal, foetal-like, non-compacted 
heart muscle structure.
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